Opinion on the importance of patient life vs. patent rights for COVID-19 Poland 2021

Published by
Adriana Sas,
Apr 10, 2024
In 2021, eight in 10 Poles believed that patients' right to health and life is more important than the patent protection granted to pharmaceutical companies that make COVID-19 vaccines.
For further information about the coronavirus (COVID-19) pandemic, please visit our dedicated Facts and Figures page.

Is patients' right to health and life more important than the patent protection afforded to pharmaceutical companies that produce coronavirus vaccines?

Loading statistic...

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

May 2021

Region

Poland

Survey time period

March 22 to April 4, 2021

Number of respondents

1,418 respondents

Age group

18 years and older

Method of interview

Computer-assisted web interviews (CAWI)

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Register now
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interest

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

Professional Account

For teams up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " The COVID-19 pandemic "

The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you The COVID-19 pandemic

Overview

6

Cases and deaths by country

8

Vaccinations

7

Focus: Public opinion

8

Further related statistics

6

Further Content: You might find this interesting as well

Statistics

Topics

Vaccine hesitancy in the U.S.Pharmaceutical industry in the U.S.Geriatric health in the U.S.Children's health in the U.S.Diseases
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Register now
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interest

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

Professional Account

For teams up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.
Menu